Safety profile of sequential transcatheter chemoembolization with DC bead™: Results of 237 hepatocellular carcinoma (HCC) patients

CardioVascular and Interventional Radiology

Volumn 34, Issue 4, 2011, Pages 774-785

  Malagari, Katerina ^a,b   Pomoni, Mary ^a   Spyridopoulos, Themistoklis N ^a,b   Moschouris, Hippokratis ^c   Kelekis, Alexis ^a,b   Dourakis, Spyros ^d   Alexopoulou, Efthymia ^b   Koskinas, John ^d   Angelopoulos, Michalis ^a   Kornezos, John ^c   Pomoni, Anastasia ^e   Tandeles, Savvas ^a   Marinis, Athanasios ^f   Rizos, Spyros ^f   Kelekis, Dimitrios ^a  

^a Evgenidion Hospital   (Greece)

^b NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^c TZANEIO GENERAL HOSPITAL OF PIRAEUS   (Greece)

^d UNIVERSITY OF ATHENS   (Greece)

^e NONE

^f Evgenidion University Hospital   (Greece)

Author keywords

Endovascular treatment; Interventional oncology; Liver hepatic

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; DOXORUBICIN; DRUG CARRIER; DRUG ELUTING BEAD; LIVER ENZYME; UNCLASSIFIED DRUG;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALOPECIA; ARTICLE; ASCITES; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BONE MARROW SUPPRESSION; BRAIN DISEASE; CANCER MORTALITY; CHEMOEMBOLIZATION; CHOLECYSTITIS; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG SAFETY; ERYTHEMA; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMAN; IATROGENIC DISEASE; LIVER ABSCESS; LIVER CELL CARCINOMA; LIVER DYSFUNCTION; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; OUTCOME ASSESSMENT; PANCREATITIS; PARTICLE SIZE; PLEURA EFFUSION; POSTEMBOLIZATION SYNDROME; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEPSIS; SIDE EFFECT; SKIN DISCOLORATION; TREATMENT DURATION;

AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; DOXORUBICIN; FEMALE; FOLLOW-UP STUDIES; GREECE; HUMANS; LIVER FUNCTION TESTS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING;

EID: 79960918424     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-010-0044-3     Document Type: Article

References (47)

1. CM Lo H Ngan WK Tso, et al. 2002 Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma Hepatology 35 1164 1171 11981766 10.1053/jhep.2002.33156 1:CAS:528:DC%2BD38XktF2hu7w%3D (Pubitemid 34454013)
2. JM Llovet MI Real X Montana, et al. 2002 Barcelona Liver Cancer Group. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial Lancet 359 1734 1739 12049862 10.1016/S0140-6736(02)08649-X (Pubitemid 34607087)
3. C Cammà F Schepis A Orlando, et al. 2002 Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials Radiology 224 1 47 54 12091661 10.1148/radiol. 2241011262 (Pubitemid 34680374)
4. M Varela MI Real M Burrel, et al. 2007 Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics J Hepatol 46 3 474 481 17239480 10.1016/j.jhep.2006.10.020 1:CAS:528:DC%2BD2sXhtlCmtb0%3D (Pubitemid 46201723)
5. RN Poon WK Tso RWC Pang, et al. 2007 A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead Clin Gastroenterol Hepatol 5 1100 1108 17627902 10.1016/j.cgh.2007.04.021 1:CAS:528:DC%2BD2sXhtFKrt7%2FE
6. K Malagari K Chatzimichael E Alexopoulou, et al. 2008 Transarterial chemoembolisation of unresectable hepatocellular carcinoma (HCC) with drug eluting beads (DEB); results of an open label study of 62 patients Cardiovasc Intervent Radiol 31 269 280 17999110 10.1007/s00270-007-9226-z
7. ™ Abdom Imaging 33 5 512 519 17938995 10.1007/s00261-007-9334-x
8. J Kettenbach A Stadler I Katzler, et al. 2008 Drug-loaded microspheres for the treatment of liver cancer: review of current results Cardiovasc Intervent Radiol 31 468 476 18228095 10.1007/s00270-007-9280-6
9. K Malagari M Pomoni A Kelekis, et al. 2010 Prospective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma Cardiovasc Intervent Radiol 33 3 541 551 19937027 10.1007/s00270-009-9750-0
10. J Lammer K Malagari T Vogl, et al. 2010 PRECISION V Investigators Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study Cardiovasc Intervent Radiol 33 1 41 52 19908093 10.1007/s00270-009-9711-7
11. National Cancer Institute (2003) Common terminology criteria for adverse events, version 3.0. National Cancer Institute, Bethesda, MD
12. Common Terminology Criteria for Adverse Events (CTCAE) v3.0, Publish Date: June 10, 2003, Notice of Modifications (March 31, 2003-June 10, 2003)
13. Vogl TJ, Lee C, Lencioni R et al (2010) Liver, gastrointestinal and cardiac toxicity in intermediate hepatocellular carcinoma treated with PRECISION TACE with drug-eluting beads: results from the PRECISION V randomized trial ECR 2010-B241, p 311
14. W Kim TW Clark RA Baum, et al. 2001 Risk factors for liver abscess formation after hepatic chemoembolization J Vasc Interv Radiol 12 965 968 11487677 10.1016/S1051-0443(07)61577-2 1:STN:280:DC%2BD3MvktFOrtw%3D%3D (Pubitemid 32756867)
15. P Del Poggio A Maddeo G Zabbialini, et al. 2007 Chemoembolization of hepatocellular carcinoma with drug eluting beads J Hepatol 47 157 159 17509721 10.1016/j.jhep.2007.04.003 1:CAS:528:DC%2BD2sXmtVahtL0%3D (Pubitemid 46881042)
16. SY Song J Chung KW Han, et al. 2001 Liver abscess after transcatheter oily chemoembolization for hepatic tumors: Incidence, predisposing factors, and clinical outcome J Vasc Interv Radiol 12 3 313 320 11287508 10.1016/S1051- 0443(07)61910-1 1:STN:280:DC%2BD3M3itVamsA%3D%3D
17. RT Poon H Ngan CM Lo, et al. 2000 Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence J Surg Oncol 73 109 114 10694648 10.1002/(SICI)1096-9098(200002)73:2<109::AID- JSO10>3.0.CO;2-J 1:STN:280:DC%2BD3c7mtVOrtA%3D%3D (Pubitemid 30123735)
18. T de Baere A Roche JM Amenabar, et al. 1996 Liver abscess formation after local treatment of liver tumors Hepatology 23 1436 1440 8675161 10.1002/hep.510230620 (Pubitemid 26181226)
19. PG Tarazov VN Polysalov KV Prozorovskij, et al. 2000 Ischemic complications of transcatheter arterial chemoembolization in liver malignancies Acta Radiol 41 156 160 10741789 10.1080/028418500127344966 1:STN:280: DC%2BD3c3gtlygsQ%3D%3D
20. AO Chan MF Yuen CK Hui, et al. 2002 A prospective study regarding the complications of transcatheter intraarterial lipiodol chemoembolization in patients with hepatocellular carcinoma Cancer 94 1747 1752 11920537 10.1002/cncr.10407 (Pubitemid 34241113)
21. Groupe d'Étude et de Traitment du Carcinome Hé patocellulaire 1995 A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma N Engl J Med 332 1256 1261 10.1056/NEJM199505113321903
22. JW Chung JH Park JK Han, et al. 1996 Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization Radiology 198 33 40 8539401 1:STN:280:DyaK287itlWguw%3D%3D
23. JM Chang WS Tzeng HB Pan, et al. 1994 Transcatheter arterial embolization with or without cisplatin treatment of hepatocellular carcinoma. A randomized controlled study Cancer 74 2449 2453 7922999 10.1002/1097-0142(19941101)74: 9<2449::AID-CNCR2820740910>3.0.CO;2-4 1:STN:280:DyaK2M%2FgslersA%3D%3D (Pubitemid 24320847)
24. S Katsushima T Inokuma H Oi, et al. 1997 Acute hepatic failure following transcatheter arterial embolization for the treatment of hepatocellular carcinoma Digestion 58 2 189 195 9144310 10.1159/000201443 1:STN:280: DyaK2s3ovFCjtw%3D%3D (Pubitemid 27163171)
25. SH Jeon KS Park YH Kim, et al. 2007 Incidence and risk factors of acute hepatic failure after transcatheter arterial chemoembolization for hepatocellular carcinoma Korean J Gastroenterol 50 3 176 182 17885283
26. L Marelli R Stigliano C Triantos, et al. 2007 Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies Cardiovasc Intervent Radiol 30 6 25 17103105 10.1007/s00270-006-0062-3 (Pubitemid 44900485)
27. AL Lewis RR Taylor B Hall, et al. 2006 Pharmacokinetic and safety study of doxorubicin-eluting beads in a porcine model of hepatic arterial embolization J Vasc Interv Radiol 17 8 1335 1343 16923981 10.1097/01.RVI.0000228416.21560.7F (Pubitemid 44259017)
28. X Li GS Feng CS Zheng, et al. 2003 Influence of transarterial chemoembolization on angiogenesis and expression of vascular endothelial growth factor and vasic fibroblast growth factor in rat with Walker-256 transplanted hepatoma: an experimental study World J Gastroenterol 9 2445 2449 14606073 1:CAS:528:DC%2BD3sXhtVSjtL7I (Pubitemid 37461245)
29. G Pelletier M Ducreux F Gay, et al. 1998 Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial J Hepatol 29 129 134 9696501 10.1016/S0168-8278(98)80187-6 1:CAS:528:DyaK1cXmvVWhsLk%3D (Pubitemid 28307992)
30. MS Chen J-Q Li Y-Q Zhang, et al. 2002 High-dose iodized oil transcatheter arterial chemoembolization for patients with large hepatocellular carcinoma World J Gastroenterol 8 1 74 78 11833075 (Pubitemid 34149764)
31. JP Bronowicki D Vetter F Dumas, et al. 1994 Transcatheter oily chemoembolization for hepatocellular carcinoma: a 4-year study of 127 French patients Cancer 74 16 24 7516263 10.1002/1097-0142(19940701)74:1<16::AID- CNCR2820740105>3.0.CO;2-V 1:STN:280:DyaK2c3ntlSrsw%3D%3D (Pubitemid 24187604)
32. GF Stefanini P Amorati M Biselli, et al. 1995 Efficacy of transarterial targeted treatments on survival of patients with hepatocellular carcinoma. An Italian experience Cancer 75 2427 2434 7736385 10.1002/1097-0142(19950515)75: 10<2427::AID-CNCR2820751007>3.0.CO;2-J 1:STN:280:DyaK2M3lsVChuw%3D%3D
33. K Takenaka K Yoshida T Nishizaki, et al. 1995 Postoperative prophylactic lipiodolization reduces the intrahepatic recurrence of hepatocellular carcinoma Am J Surg 169 400 404 7694977 10.1016/S0002-9610(99)80184-6 1:STN:280: DyaK2M3gvV2qtg%3D%3D
34. F Paye O Farges M Dahmane, et al. 1999 Cytolysis following chemoembolization for hepatocellular carcinoma Br J Surg 86 176 180 10100782 10.1046/j.1365-2168.1999.01014.x 1:STN:280:DyaK1M7pvVyrsw%3D%3D (Pubitemid 29090179)
35. SJ Wigmore DN Redhead BN Thomson, et al. 2003 Postchemoembolisation syndrome: tumour necrosis or hepatocyte injury? Br J Cancer 89 1423 1427 14562011 10.1038/sj.bjc.6601329 1:STN:280:DC%2BD3svotlSltQ%3D%3D (Pubitemid 37386595)
36. I Sakamoto N Aso K Nagaoki, et al. 1998 Complications associated with transcatheter arterial embolization for hepatic tumors Radiographics 18 3 605 619 9599386 1:STN:280:DyaK1c3mtFOmsA%3D%3D (Pubitemid 128467047)
37. H Nakamura H Kondoh 1986 Emphysematous cholecystitis: complication of hepatic arterial embolization Cardiovasc Intervent Radiol 9 152 153 3015409 10.1007/BF02577926 1:STN:280:DyaL283ntF2mtQ%3D%3D (Pubitemid 16064725)
38. HK Kim YH Chung BC Song, et al. 2001 Ischemic bile duct injury as a serious complication after transarterial chemoembolization in patients with hepatocellular carcinoma J Clin Gastroenterol 32 423 427 11319315 10.1097/00004836-200105000-00013 1:STN:280:DC%2BD3M3jtFSksg%3D%3D (Pubitemid 32378276)
39. MQ Wang RH Shao HY Ye, et al. 2005 Investigation of bile duct injury after transcatheter arterial chemoembolization Zhonghua Zhong Liu Za Zhi 27 609 612 16438871
40. TK Leung CM Lee HC Chen 2005 Anatomic and technical skill factor of gastroduodenal complication in post-transarterial embolization for hepatocellular carcinoma: a retrospective study of 280 cases World J Gastroenterol 11 1554 1557 15770737
41. DDB Brennan CB Farrelly RB Cooney, et al. 2005 Abdominal rash after transarterial chemoembolization via the right inferior phrenic artery J Vasc Interv Radiol 16 9 1269 16151071
42. Arora BR, Soulen BMC, Haskal ZJ 1999 Cutaneous complications of hepatic chemoembolization via extrahepatic collaterals J Vasc Interv Radiol 10 1351 1356 10584650 10.1016/S1051-0443(99)70242-3 1:STN:280:DC%2BD3c%2FkvFentw%3D%3D
43. KT Brown 2004 Fatal pulmonary complications after arterial embolization with 40- to 120-micro m tris-acryl gelatine microspheres J Vasc Interv Radiol 15 21 197 200 14963189 (Pubitemid 38248922)
44. MA Maluccio AM Covey L Ben Porat, et al. 2008 Transcatheter arterial embolization with only particles for the treatment of unresectable hepatocellular carcinoma J Vasc Interv Radiol 19 6 862 869 18503900 10.1016/j.jvir.2008.02.013
45. CL Liu H Ngan CM Lo, et al. 1998 Ruptured hepatocellular carcinoma as a complication of transarterial oily chemoembolization Br J Surg 85 512 514 9607536 10.1046/j.1365-2168.1998.00664.x 1:STN:280:DyaK1c3mvVGmsA%3D%3D (Pubitemid 28175447)
46. N Battula M Madanur O Priest, et al. 2009 Spontaneous rupture of hepatocellular carcinoma: a Western experience Am J Surg 197 2 164 167 18926518 10.1016/j.amjsurg.2007.10.016
47. SW Shin YS Do SW Choo, et al. 2006 Diaphragmatic weakness after transcatheter arterial chemoembolization of inferior phrenic artery for treatment of hepatocellular carcinoma Radiology 241 2 581 583 17005772 10.1148/radiol.2412051209 (Pubitemid 44632906)